Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
biological and medical sciences (10382) 10382
medical sciences (10379) 10379
diseases of the osteoarticular system (10357) 10357
tumors of striated muscle and skeleton (10355) 10355
humans (8869) 8869
science & technology (6657) 6657
life sciences & biomedicine (6630) 6630
male (5606) 5606
female (5311) 5311
adult (4240) 4240
middle aged (3065) 3065
adolescent (2871) 2871
child (2287) 2287
abridged index medicus (2195) 2195
oncology (2114) 2114
aged (2000) 2000
orthopedics (1970) 1970
bone neoplasms - pathology (1856) 1856
surgery (1739) 1739
tumors (1672) 1672
radiography (1289) 1289
magnetic resonance imaging (1207) 1207
tomography, x-ray computed (1161) 1161
bone neoplasms - surgery (1159) 1159
child, preschool (1037) 1037
radiology, nuclear medicine & medical imaging (1037) 1037
diagnosis, differential (1015) 1015
bone neoplasms - diagnostic imaging (1013) 1013
pathology (910) 910
follow-up studies (887) 887
retrospective studies (884) 884
prognosis (860) 860
animals (851) 851
osteosarcoma (837) 837
bone neoplasms - diagnosis (835) 835
treatment outcome (833) 833
osteosarcoma - pathology (772) 772
bone neoplasms - secondary (769) 769
immunohistochemistry (664) 664
combined modality therapy (627) 627
investigative techniques, diagnostic techniques (620) 620
bone neoplasms - drug therapy (578) 578
aged, 80 and over (570) 570
mice (564) 564
pharmacology. drug treatments (560) 560
neurosciences & neurology (538) 538
clinical neurology (515) 515
cell line, tumor (502) 502
bone neoplasms - genetics (501) 501
infant (491) 491
antineoplastic agents (472) 472
metastasis (465) 465
bone neoplasms - metabolism (463) 463
bone neoplasms - therapy (435) 435
cancer (427) 427
antineoplastic combined chemotherapy protocols - therapeutic use (411) 411
medicine & public health (408) 408
bone neoplasms - mortality (382) 382
soft tissue neoplasms - pathology (376) 376
osteosarcoma - surgery (375) 375
pediatrics (365) 365
osteosarcoma - drug therapy (362) 362
young adult (351) 351
lung neoplasms - secondary (350) 350
survival rate (349) 349
time factors (348) 348
chondrosarcoma - pathology (345) 345
sarcoma, ewing - pathology (343) 343
sarcoma (339) 339
surgery. transplantations, organ and tissue grafts. graft diseases (339) 339
chemotherapy (338) 338
biopsy (325) 325
osteosarcoma - genetics (320) 320
radionuclide imaging (318) 318
tumor cells, cultured (317) 317
care and treatment (312) 312
osteosarcoma - metabolism (309) 309
pathology. cytology. biochemistry. spectrometry. miscellaneous investigative techniques (308) 308
neoplasm recurrence, local (300) 300
disease-free survival (298) 298
bone neoplasms - complications (297) 297
neoplasm staging (296) 296
orthopedic surgery (292) 292
survival analysis (291) 291
rhabdomyosarcoma (288) 288
otorhinolaryngology. stomatology (282) 282
research (277) 277
neoplasm metastasis (276) 276
dermatology (274) 274
ewing's sarcoma (272) 272
spinal neoplasms - surgery (265) 265
genetics & heredity (259) 259
chondrosarcoma (256) 256
osteosarcoma - diagnostic imaging (251) 251
reverse transcriptase polymerase chain reaction (247) 247
soft tissue neoplasms - surgery (242) 242
risk factors (238) 238
fundamental and applied biological sciences. psychology (232) 232
analysis (229) 229
gene expression regulation, neoplastic (229) 229
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Molecular mechanisms of bone metastasis and associated muscle weakness
by Waning, David L and Guise, Theresa A
Clinical cancer research, ISSN 1078-0432, 06/2014, Volume 20, Issue 12, pp. 3071 - 3077
Life Sciences & Biomedicine | Oncology | Science & Technology | Pharmacology. Drug treatments | Diseases of the osteoarticular system | Tumors of striated muscle and skeleton | Biological and medical sciences | Multiple tumors. Solid tumors. Tumors in childhood (general aspects) | Medical sciences | Antineoplastic agents | Tumors | Muscle Weakness - etiology | Animals | Prognosis | Breast Neoplasms - pathology | Humans | Muscle Weakness - pathology | Bone Neoplasms - secondary | Female | Bone Neoplasms - complications | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Magnetic Resonance Imaging of the Axial Skeleton for Detecting Bone Metastases in Patients With High-Risk Prostate Cancer: Diagnostic and Cost-Effectiveness and Comparison With Current Detection Strategies
by Frédéric E. Lecouvet and Daphné Geukens and Annabelle Stainier and François Jamar and Jacques Jamart and Bertrand Janne d'Othée and Patrick Therasse and Bruno Vande Berg and Bertrand Tombal
Journal of clinical oncology, ISSN 0732-183X, 08/2007, Volume 25, Issue 22, pp. 3281 - 3287
Life Sciences & Biomedicine | Oncology | Science & Technology | Biological and medical sciences | Medical sciences | Diseases of the osteoarticular system | Tumors of striated muscle and skeleton | Tumors | Prostatic Neoplasms - pathology | Bone Neoplasms - diagnosis | Prospective Studies | Bone Neoplasms - diagnostic imaging | Humans | Middle Aged | Bone Neoplasms - secondary | Magnetic Resonance Imaging - methods | Male | Magnetic Resonance Imaging - economics | Diagnostic Imaging - methods | Radiography | Cost-Benefit Analysis | Sensitivity and Specificity | Radionuclide Imaging | Aged, 80 and over | Aged | Diagnostic Imaging - economics | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Osteosarcoma treatment – Where do we stand? A state of the art review
by Luetke, Anja and Meyers, Paul A and Lewis, Ian and Juergens, Heribert
Cancer treatment reviews, ISSN 0305-7372, 2014, Volume 40, Issue 4, pp. 523 - 532
Hematology, Oncology and Palliative Medicine | Metastatic disease | Mifamurtide | Osteosarcoma | Outcome | Systemic treatment | Prognostic factors | Interferon α | Life Sciences & Biomedicine | Oncology | Science & Technology | Pharmacology. Drug treatments | Diseases of the osteoarticular system | Tumors of striated muscle and skeleton | Biological and medical sciences | Multiple tumors. Solid tumors. Tumors in childhood (general aspects) | Medical sciences | Antineoplastic agents | Tumors | Neoplasm Grading | Bone Neoplasms - therapy | Bone Neoplasms - pathology | Osteosarcoma - therapy | Humans | Osteosarcoma - pathology | Chemotherapy | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Attenuation of proteasome-induced proteolysis in skeletal muscle by β-hydroxy-β-methylbutyrate in cancer-induced muscle loss
by Smith, Helen J and Mukerji, Pradip and Tisdale, Michael J
Cancer research (Chicago, Ill.), ISSN 0008-5472, 01/2005, Volume 65, Issue 1, pp. 277 - 283
Life Sciences & Biomedicine | Oncology | Science & Technology | Biological and medical sciences | Medical sciences | Antineoplastic agents | Pharmacology. Drug treatments | Diseases of the osteoarticular system | Tumors of striated muscle and skeleton
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text miRNA signatures associate with pathogenesis and progression of osteosarcoma
by Jones, Kevin B and Salah, Zaidoun and Del Mare, Sara and Galasso, Marco and Gaudio, Eugenio and Nuovo, Gerard J and Lovat, Francesca and LeBlanc, Kimberly and Palatini, Jeff and Randall, R. Lor and Volinia, Stefano and Stein, Gary S and Croce, Carlo M and Lian, Jane B and Aqeilan, Rami I
Cancer research (Chicago, Ill.), ISSN 0008-5472, 04/2012, Volume 72, Issue 7, pp. 1865 - 1877
Life Sciences & Biomedicine | Oncology | Science & Technology | Pharmacology. Drug treatments | Diseases of the osteoarticular system | Tumors of striated muscle and skeleton | Biological and medical sciences | Medical sciences | Antineoplastic agents | Tumors | Osteosarcoma - drug therapy | NIH 3T3 Cells | Humans | Osteosarcoma - etiology | Bone Neoplasms - etiology | Disease Progression | Animals | Cell Line, Tumor | Bone Neoplasms - genetics | Mice | Bone Neoplasms - drug therapy | MicroRNAs - physiology | Osteosarcoma - genetics | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Sarcoma classification: An update based on the 2013 World Health Organization Classification of Tumors of Soft Tissue and Bone
by Doyle, Leona A
Cancer, ISSN 0008-543X, 06/2014, Volume 120, Issue 12, pp. 1763 - 1774
bone | soft tissue | sarcoma | World Health Organization | tumor classification | tumor | Life Sciences & Biomedicine | Oncology | Science & Technology | Biological and medical sciences | Multiple tumors. Solid tumors. Tumors in childhood (general aspects) | Medical sciences | Diseases of the osteoarticular system | Tumors of striated muscle and skeleton | Tumors | Sarcoma - classification | Humans | Soft Tissue Neoplasms - classification | Soft Tissue Neoplasms - pathology | Sarcoma - pathology | Bone Neoplasms - classification | Bone Neoplasms - pathology | Bone cancer | Care and treatment | Sarcoma | Identification and classification | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Randomized, Double-Blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma
by David H. Henry and Luis Costa and Francois Goldwasser and Vera Hirsh and Vania Hungria and Jana Prausova and Giorgio Vittorio Scagliotti and Harm Sleeboom and Andrew Spencer and Saroj Vadhan-Raj and Roger von Moos and Wolfgang Willenbacher and Penella J. Woll and Jianming Wang and Qi Jiang and Susie Jun and Roger Dansey and Howard Yeh
Journal of clinical oncology, ISSN 0732-183X, 03/2011, Volume 29, Issue 9, pp. 1125 - 1132
Life Sciences & Biomedicine | Oncology | Science & Technology | Biological and medical sciences | Medical sciences | Diseases of the osteoarticular system | Tumors of striated muscle and skeleton | Tumors | Humans | Middle Aged | Bone Neoplasms - secondary | Antibodies, Monoclonal - therapeutic use | Male | Young Adult | Antibodies, Monoclonal, Humanized | Multiple Myeloma - drug therapy | Aged, 80 and over | Diphosphonates - therapeutic use | Adult | Female | Bone Neoplasms - drug therapy | Imidazoles - therapeutic use | RANK Ligand - therapeutic use | Double-Blind Method | Bone Density Conservation Agents - therapeutic use | Survival Rate | Treatment Outcome | Denosumab | Neoplasms - drug therapy | Multiple Myeloma - pathology | International Agencies | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Aged | Neoplasms - pathology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Neo/adjuvant chemotherapy does not improve outcome in resected primary synovial sarcoma: a study of the French Sarcoma Group
by Italiano, A and Penel, N and Robin, Y.-M and Bui, B and Le Cesne, A and Piperno-Neumann, S and Tubiana-Hulin, M and Bompas, E and Chevreau, C and Isambert, N and Leyvraz, S and du Chatelard, P. P and Thyss, A and Coindre, J.-M and Blay, J.-Y
Annals of oncology, ISSN 0923-7534, 3/2009, Volume 20, Issue 3, pp. 425 - 430
Adjuvant chemotherapy | Neo-adjuvant chemotherapy | Radiotherapysynovial sarcoma | Life Sciences & Biomedicine | Oncology | Science & Technology | Biological and medical sciences | Medical sciences | Antineoplastic agents | Pharmacology. Drug treatments | Diseases of the osteoarticular system | Tumors of striated muscle and skeleton | Humans | Middle Aged | Male | Treatment Outcome | Antineoplastic Agents - therapeutic use | Combined Modality Therapy | Sarcoma, Synovial - surgery | Sarcoma, Synovial - drug therapy | Adolescent | Survival Analysis | Adult | Female | Aged | Chemotherapy, Adjuvant | France | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text R1507, a Monoclonal Antibody to the Insulin-Like Growth Factor 1 Receptor, in Patients With Recurrent or Refractory Ewing Sarcoma Family of Tumors: Results of a Phase II Sarcoma Alliance for Research Through Collaboration Study
by Alberto S. Pappo and Shreyaskumar R. Patel and John Crowley and Denise K. Reinke and Klaus-Peter Kuenkele and Sant P. Chawla and Guy C. Toner and Robert G. Maki and Paul A. Meyers and Rashmi Chugh and Kristen N. Ganjoo and Scott M. Schuetze and Heribert Juergens and Michael G. Leahy and Birgit Geoerger and Robert S. Benjamin and Lee J. Helman and Laurence H. Baker
Journal of clinical oncology, ISSN 0732-183X, 12/2011, Volume 29, Issue 34, pp. 4541 - 4547
Life Sciences & Biomedicine | Oncology | Science & Technology | Biological and medical sciences | Medical sciences | Diseases of the osteoarticular system | Tumors of striated muscle and skeleton | Tumors | Recurrence | Drug Administration Schedule | Humans | Middle Aged | Antibodies, Monoclonal - therapeutic use | Treatment Outcome | Antineoplastic Agents - therapeutic use | Sarcoma, Ewing - drug therapy | Adolescent | Receptor, IGF Type 1 - immunology | Adult | Aged | Bone Neoplasms - drug therapy | Child | Index Medicus | Original Reports | Pedi5 | Sarc1
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours
by Amary, M Fernanda and Bacsi, Krisztian and Maggiani, Francesca and Damato, Stephen and Halai, Dina and Berisha, Fitim and Pollock, Robin and O'Donnell, Paul and Grigoriadis, Anita and Diss, Tim and Eskandarpour, Malihe and Presneau, Nadège and Hogendoorn, Pancras CW and Futreal, Andrew and Tirabosco, Roberto and Flanagan, Adrienne M
The Journal of pathology, ISSN 0022-3417, 07/2011, Volume 224, Issue 3, pp. 334 - 343
mutation | enchondroma | sarcoma | IDH1 | IDH2 | chondrosarcoma | mosaic | Ollier disease | Pathology | Oncology | Life Sciences & Biomedicine | Science & Technology | Biological and medical sciences | Investigative techniques, diagnostic techniques (general aspects) | Medical sciences | Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques | Diseases of the osteoarticular system | Tumors of striated muscle and skeleton | Bone Neoplasms - diagnosis | Chondroma - diagnosis | Follow-Up Studies | Humans | Chondroma - genetics | Isocitrate Dehydrogenase - genetics | Male | Bone Neoplasms - pathology | Chondroma - pathology | Magnetic Resonance Imaging | Chondrosarcoma - genetics | Chondrosarcoma - pathology | Germ-Line Mutation | Female | Bone Neoplasms - genetics | Mutation | Osteosarcoma - genetics | Enchondromatosis - pathology | Enchondromatosis - genetics | Osteosarcoma - pathology | hemangioma | Enzymes | Chondrosarcoma | Mosaics | Mesenchyme | Brain tumors | Mass spectroscopy | Bone tumors | Soft tissues | Chondroma | Glioma | Osteosarcoma | Tumorigenesis | Immunoreactivity | Isocitrate dehydrogenase | osteochondroma | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study
by Fizazi, Karim, Prof and Carducci, Michael, MD and Smith, Matthew, MD and Damião, Ronaldo, Prof and Brown, Janet, MD and Karsh, Lawrence, MD and Milecki, Piotr, MD and Shore, Neal, MD and Rader, Michael, MD and Wang, Huei, PhD and Jiang, Qi, PhD and Tadros, Sylvia, MPH and Dansey, Roger, MD and Goessl, Carsten, MD
The Lancet (British edition), ISSN 0140-6736, 2011, Volume 377, Issue 9768, pp. 813 - 822
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Tumors of the urinary system | Urinary tract. Prostate gland | General aspects | Diseases of the osteoarticular system | Tumors of striated muscle and skeleton | Nephrology. Urinary tract diseases | Biological and medical sciences | Medical sciences | Prostatic Neoplasms - pathology | Bone Density Conservation Agents - adverse effects | Prostatic Neoplasms - surgery | Humans | Imidazoles - adverse effects | Middle Aged | Antibodies, Monoclonal - adverse effects | Bone Density Conservation Agents - therapeutic use | Bone Neoplasms - secondary | Antibodies, Monoclonal - therapeutic use | Male | Denosumab | Orchiectomy | Antibodies, Monoclonal, Humanized | Diphosphonates - therapeutic use | Aged | Bone Neoplasms - drug therapy | Imidazoles - therapeutic use | RANK Ligand - therapeutic use | Diphosphonates - adverse effects | RANK Ligand - adverse effects | Usage | Patient outcomes | Zoledronic acid | Metastasis | Research | Drug therapy | Comparative analysis | Fees & charges | Acids | Conferences | Patient safety | Public speaking | Clinical medicine | Prostate cancer | Cancer therapies | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights